Skip to main content
Article thumbnail
Location of Repository

Is progression of IgA nephropathy conditioned by genes regulating atherosclerotic damage?

By Rosanna Coppo and John Feehally

Abstract

Progress has been slow in identifying genetic factors that influence either susceptibility to IgA nephropathy (IgAN) or its progression to end-stage renal disease (ESRD) [1]. Studies of both familial and sporadic IgAN strongly point to clinical and genetic heterogeneity in the entity we presently call IgAN. The human IgAN phenotype does not exhibit classic Mendelian inheritance patterns, but is better considered using the paradigm for genetically complex human autoimmune diseases, for which multiple loci have been identified by family-based genetic studies. In these complex diseases many different types of genetic variations contribute to the final phenotype. Among the many potential mechanisms involved, interest has recently been focused on specific single-nucleotide polymorphism (SNP) alleles that alter the transcriptional activity of genes involved in the pathogenesis. Recently, it has been said that 30–50% of human genes with coding SNPs can present allelic variation in gene expression [2].Peer reviewedPost prin

Publisher: Oxford University Press (OUP)
Year: 2009
DOI identifier: 10.1093/ndt
OAI identifier: oai:lra.le.ac.uk:2381/8094
Journal:

Suggested articles

Citations

  1. (2006). Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.J Am Soc Nephrol. doi
  2. (2008). The glomerular response to IgA deposition in IgA nephropathy. Semin Nephrol. doi
  3. (1993). Angiotensin II local hyperreactivity in the progression of IgA nephropathy. doi
  4. (2006). Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis. doi
  5. (2002). A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int doi
  6. (2004). Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. Clin Nephrol doi
  7. (2001). Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. doi
  8. (2000). Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant doi
  9. (2007). alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res. doi
  10. (1997). Expression of beta 1 integrins in IgA nephropathy. Nephrol Dial Transplant doi
  11. (1999). Ruoslahti E: Integrin signaling. Science doi
  12. (1996). Amore A,et al: Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin. Kidney Int doi
  13. (2008). Expression of endothelial intercellular adhesion molecule1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol doi
  14. (2002). C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction. doi
  15. (1994). Expression of intercellular adhesion molecule-1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy. Nephron doi
  16. (2003). Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.